Objective To understand the epidemiology, current treatment, and disease burden of
systemic lupus erythematosus (SLE) in the Asia Pacific (APAC) region. Methods A targeted …

Background Patients with systemic lupus erythematosus have substantial unmet medical
need. Baricitinib is an oral selective Janus kinase (JAK) 1 and JAK2 inhibitor that we …

SLE is a costly disease that disproportionately affects disadvantaged populations. Future
economic studies should measure not only direct costs, but also incorporate indirect costs …

Objective Childhood‐onset systemic lupus erythematosus (SLE) is a severe, lifelong,
multisystem autoimmune disease. Long‐term outcome data are limited. This study was …

We aimed to identify risk factors for persistently reduced health-related quality of life in
childhood-onset lupus and describe a risk profile for persistently reduced health-related …

Background Depressive and anxiety symptoms are common in children and youth and may
impact outcomes for individuals with childhood-onset systemic lupus erythematosus …

Background As chronic conditions, rare and complex connective tissue and musculoskeletal
diseases (rCTDs) significantly affect the quality of life generating an impact on the physical …

Systemic lupus erythematosus (SLE) is an autoimmune disorder with significant health
disparities, as it disproportionately and more severely affects vulnerable and disadvantaged …

Objective We explored damage occurrence in patients with childhood-onset SLE (cSLE) and
aimed to predict the risk of organ damage occurrence in time. Methods The retrospective …

Objective In this paper, we aim to define factors associated with health-related quality of life
(HRQoL) in Mestizo patients with systemic lupus erythematosus (SLE). Methods We …